GB858531419A
GB8531419D0
(en)
|
1985-12-20 |
1985-12-20 |
Pindolol compositions
|
HU864004A
HU197201B
(en)
|
1985-10-01 |
1986-09-19 |
Process for producing oral pharmaceutical compositions of controlled solubility of the active components
|
NL8602370A
NL194822C
(en)
|
1985-10-01 |
1986-09-19 |
Preparation for oral administration with controlled release and method for its preparation.
|
CH3780/86A
CH669524A5
(en)
|
1985-10-01 |
1986-09-22 |
|
DE3632201A
DE3632201C2
(en)
|
1985-10-01 |
1986-09-23 |
Pharmaceutical composition with sustained release of the active substance
|
SE8604112A
SE503222C2
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical preparations with controlled release of isradipine or darodipine
|
GB8623389A
GB2181053B
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical formulations with controlled release of the active substance
|
IE256586A
IE59589B1
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical formulations with controlled release of the active substance
|
CA000519302A
CA1298784C
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical formulations with controlled release of the active substance
|
GR862457A
GR862457B
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical formulations with controlled release of the active substance
|
IL80182A
IL80182A
(en)
|
1985-10-01 |
1986-09-29 |
Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance
|
KR1019860008136A
KR920008817B1
(en)
|
1985-10-01 |
1986-09-29 |
Process for the preparing pharmaceutical formulations with controlled release of the active substance
|
NZ217732A
NZ217732A
(en)
|
1985-10-01 |
1986-09-29 |
Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
|
AU63226/86A
AU598751B2
(en)
|
1985-02-07 |
1986-09-29 |
Pharmaceutical formulations with controlled release of the active substance
|
PT83456A
PT83456B
(en)
|
1985-10-01 |
1986-09-29 |
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE
|
DK464686A
DK170016B1
(en)
|
1985-10-01 |
1986-09-29 |
Composition with controlled release of the active substance
|
AT0260486A
AT402257B
(en)
|
1985-10-01 |
1986-09-30 |
METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF A 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER ACTIVE SUBSTANCE
|
LU86615A
LU86615A1
(en)
|
1985-10-01 |
1986-09-30 |
NEW EXTENDED RELEASE FORMULATION
|
IT8648494A
IT1214719B
(en)
|
1985-10-01 |
1986-09-30 |
Controlled release cardiovascular preparations
|
BE1/011554A
BE905516A
(en)
|
1985-10-01 |
1986-09-30 |
NEW EXTENDED RELEASE FORMULATION.
|
ES8602313A
ES2002508A6
(en)
|
1985-10-01 |
1986-09-30 |
New sustained-release formulation based on pindolol
|
FR868613668A
FR2589732B1
(en)
|
1985-10-01 |
1986-10-01 |
NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL
|
SG1033/91A
SG103391G
(en)
|
1985-10-01 |
1991-12-04 |
Pharmaceutical formulations with controlled release of the active substance
|
HK3/92A
HK392A
(en)
|
1985-10-01 |
1992-01-02 |
Pharmaceutical formulations with controlled release of the active substance
|
MX9203614A
MX9203614A
(en)
|
1985-10-01 |
1992-06-26 |
PHARMACEUTICAL FORMULATION OF CONTROLLED RELEASE FOR ORAL ADMINISTRATION.
|
CY1622A
CY1622A
(en)
|
1985-10-01 |
1992-07-10 |
Pharmaceutical formulations with controlled release of the active substance
|